VCEL (vcel.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Vericel Corp (VCEL)

The Vericel Corporation (VCEL) price chart on the GURU.Markets platform reflects the momentum of a regenerative medicine leader advancing tissue bioengineering. Vericel Corporation generates revenue from exclusive implants for burn and joint treatment, with costs at the level of 5.96 supported by insurance payouts. Strict biomaterial production regulations and unique patents create a high barrier to entry, rendering the business virtually inaccessible to new players.

VCEL Vericel Inc.: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Vericel Corp (VCEL)

- rega lan prakiraan konsensus rega:
Bagan rega Vericel Corporation|VCEL - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Vericel Corp.|VCEL - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Vericel|VCEL - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku vcel.com|VCEL - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Vericel Corporation|VCEL - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Vericel Corp.|VCEL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Vericel Corp.|VCEL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Vericel
Analisis wiwitan perusahaan:Vericel Corporation - VCEL
Produk asli Vericel Corp.

Vericel Corporation occupies a niche as a high-tech cell therapy manufacturer, maintaining critical production capacities in-house to minimize outsourcing risks. By analyzing the current market capitalization-to-book value ratio, an investor determines the market valuation multiple relative to net assets, which allows for the identification of overbought shares and an assessment of the real value of every dollar of the company's equity.

Pesaing utama

Krystal Biotech, Inc. (KRYS) - Rasio Nilai Pasar marang Nilai Buku|APGE (apogeetherapeutics.com) - Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Arcutis Biotherapeutics, Inc. ARQT|Kapitalisasi Pasar marang Aset Bersih Oruka Therapeutics, Inc.|Sanara MedTech Inc. (SMTI) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku dbv-technologies.com (DBVT)|Rasio Kapitalisasi Pasar marang Nilai Buku SLSN (Solesence)|Journey Medical Corp - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Forte Biosciences (FBRX)|EMPG: Nilai Pasar marang Nilai Buku|SLGL (Sol-Gel) - Rasio Nilai Pasar marang Nilai Buku|AXIL Brands (AXIL) - Rasio Kapitalisasi marang Aset Bersih|MDCX (Medicus Pharma Ltd.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Verrica (VRCA)|Hoth Therapeutics, Inc. (HOTH) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku BFRI (biofrontera-us.com)|Rasio Nilai Pasar marang Nilai Buku VYNE|Sonoma Pharmaceuticals Inc. - Kapitalisasi Pasar marang Nilai Buku|Quoin Pharma - Rasio Nilai Pasar marang Nilai Buku|AZTR - Rasio Kapitalisasi Pasar marang Nilai Buku|Dermata Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|ELAB (Elevai Labs Inc) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Revance Therapeutics, Inc (RVNC)